WASHINGTON (May 19, 2016)—Several members of the House Science, Space and Technology Committee have sent letters to 17 state attorneys general, the Union of Concerned Scientists and other groups, requesting that they turn over documents and communications among the groups related to investigations into ExxonMobil. Attorneys general from California, Massachusetts, New York, and the U.S. Virgin Islands are investigating whether ExxonMobil lied to its shareholders and the public about the threat of climate change.
Below is a statement by Ken Kimmell, president of the Union of Concerned Scientists.
“The premise of Chairman Smith’s letter is a farce. The attorneys general are not investigating ExxonMobil’s scientific research, but rather whether the company misled shareholders and the public about the dangers of climate change in order to continue profiting from a lucrative product. Documents uncovered by UCS and others reveal that scientists with Exxon and other companies knew about the causes and consequences of climate change by the 1970s, but company leaders chose to deny, disparage and downplay this evidence to avoid sensible regulation.
“We are unapologetic about our efforts to expose this deception, and we will not be intimidated by this tactic. Record temperatures, rising seas and unprecedented flooding affects people around the globe and they rightly expect carbon producers to be held accountable for their deliberate strategy to deceive the public, shareholders and policy makers.
“It’s ironic that Representative Smith sees our work as an attempt to stifle scientific discourse, when he has spent the last 10 months harassing National Oceanic and Atmospheric Administration scientists whose research he doesn’t like. This abuse of power has been repeatedly and strongly rebuked by the scientific community.
“In keeping with Mr. Smith’s calls for transparency, the public should demand that oil companies fully disclose what their scientists knew about climate change and when. And more importantly, the public deserves to know which industry executives made decisions to mislead shareholders, policy makers and investors about the harm of their products.”